• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS ONE. Disruption of the Human Gut Microbiota following Norovirus Infection

Giuseppe

Emeritus
[Source: PLoS ONE, full text: (LINK). Abstract, edited.]

Disruption of the Human Gut Microbiota following Norovirus Infection


Adam M. Nelson<SUP>1</SUP><SUP>,</SUP><SUP>2</SUP><SUP>*</SUP>, Seth T. Walk<SUP>2</SUP>, Stefan Taube<SUP>3</SUP>, Mami Taniuchi<SUP>4</SUP>, Eric R. Houpt<SUP>4</SUP>, Christiane E. Wobus<SUP>3</SUP>, Vincent B. Young<SUP>2</SUP><SUP>,</SUP><SUP>3</SUP>
<SUP></SUP>
1 Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America, 2 Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, Michigan, United States of America, 3 Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America, 4 Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, United States of America



Abstract

The gut microbiota, the collection of all bacterial members in the intestinal tract, plays a key role in health. Disruption of the indigenous microbiota by a variety of stressors, including antibiotic therapy and intestinal infections, is associated with multiple health problems. We sought to determine if infection with Norovirus disrupts the gut microbiota. Barcoded pyrosequencing of the 16S rRNA-encoding gene was used to characterize the stool microbiota in Norovirus-infected human patients (n = 38). While the microbiota in most infected patients (n = 31) resembled that seen in uninfected healthy controls, a minority of patients (n = 7) possessed a significantly altered microbiota characterized by reduced relative numbers of Bacteriodetes and a corresponding increase in Proteobacteria. In these patients, the increase in Proteobacteria was due to a single operational taxonomic unit (OTU) of Escherichia coli. We cultured E. coli from Norovirus-infected patients and characterized them using PCR-ribotyping and virulence factor analysis. Multiple ribotypes were encountered, but none possessed typical virulence factors commonly carried by enteropathogenic E. coli strains. Microbiota disruption and elevated Proteobacteria were not significantly correlated to patient age, gender, sampling time following illness onset, or overall gut inflammation. These results demonstrate that some patients have a disrupted microbiota following Norovirus infection, and therefore may be at elevated risk for long-term health complications.



Citation: Nelson AM, Walk ST, Taube S, Taniuchi M, Houpt ER, et al. (2012) Disruption of the Human Gut Microbiota following Norovirus Infection. PLoS ONE 7(10): e48224. doi:10.1371/journal.pone.0048224

Editor: Yolanda Sanz, Instutite of Agrochemistry and Food Technology, Spain

Received: May 30, 2012; Accepted: September 21, 2012; Published: October 30, 2012

Copyright: ? 2012 Nelson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This study was supported by Award Number 5 U01 AI075396 from the National Institute of Allergy and Infectious Diseases (NIAID) to V.B.Y., the University of Michigan T32 Pulmonary training grant to A.M.N., the Biological Sciences Scholars Program and start-up funds from the University of Michigan to C.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.


* E-mail: nelso222@gmail.com
-
------
 
Back
Top